Dr. Xu Danfeng (徐丹枫) - Director of Urology at Ruijin Hospital Shanghai

Introduction

Dr. Xu Danfeng (徐丹枫) is the Director of the Department of Urology at Ruijin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, and one of China's most accomplished and innovative urologists. With over 20 years of specialized experience, Dr. Xu is nationally recognized for his expertise in urologic oncology, robotic and laparoscopic urologic surgery, and the minimally invasive treatment of prostate cancer, bladder cancer, kidney cancer, and adrenal tumors. He is a leading practitioner of robotic urologic surgery in Shanghai and has been instrumental in advancing minimally invasive urologic oncology at one of China's most prestigious academic medical centers. His dedication to surgical precision, oncologic excellence, and patient-centered care has made Ruijin Hospital's Department of Urology a premier destination for patients with complex urologic conditions, including international patients seeking expert urologic care in Shanghai.

Academic Distinctions & Leadership

• Director, Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
• Professor of Urology, Shanghai Jiao Tong University School of Medicine
• Chief Physician, Ruijin Hospital
• Member, Urology Branch, Chinese Medical Association
• Member, Chinese Anti-Cancer Association, Urologic Oncology Committee
• Member, European Association of Urology (EAU)
• Member, American Urological Association (AUA)
• Member, Endourological Society
• Member, Society of Urologic Oncology (SUO)
• Editorial Board Member, multiple leading urology journals
• Recipient, Shanghai Science and Technology Award
• Recipient, Shanghai Medical Science and Technology Award
• Recipient, Wu Jieping Medical Innovation Award

Specializations & Expertise

Prostate Cancer Surgery

• Robotic-assisted radical prostatectomy (RARP) — nerve-sparing and standard
• Laparoscopic radical prostatectomy
• Extended pelvic lymph node dissection
• Salvage prostatectomy after radiation failure
• Surgery for locally advanced and high-risk prostate cancer
• Focal therapy coordination (HIFU, cryotherapy) for eligible patients

Bladder Cancer Surgery

• Robotic-assisted radical cystectomy with urinary diversion
• Laparoscopic radical cystectomy
• Orthotopic neobladder reconstruction (Studer pouch and variants)
• Ileal conduit urinary diversion
• Continent cutaneous urinary diversion
• Transurethral resection of bladder tumor (TURBT) — standard and en bloc
• Bladder-sparing multimodal therapy coordination
• Intravesical BCG and chemotherapy coordination

Kidney Cancer Surgery

• Robotic-assisted partial nephrectomy (nephron-sparing surgery)
• Laparoscopic partial and radical nephrectomy (transperitoneal and retroperitoneal)
• Open radical nephrectomy with inferior vena cava thrombectomy for advanced disease
• Surgery for locally advanced and metastatic renal cell carcinoma
• Ablative therapy coordination (RFA, cryoablation) for small renal masses
• Cytoreductive nephrectomy for metastatic RCC

Adrenal Surgery

• Laparoscopic adrenalectomy for adrenal tumors (adenoma, pheochromocytoma, carcinoma)
• Robotic-assisted adrenalectomy
• Retroperitoneal laparoscopic adrenalectomy
• Bilateral adrenalectomy
• Surgery for adrenocortical carcinoma

Upper Tract Urothelial Carcinoma

• Robotic-assisted nephroureterectomy with bladder cuff excision
• Laparoscopic nephroureterectomy
• Endoscopic management of low-grade upper tract tumors
• Segmental ureterectomy for distal ureteral tumors

Minimally Invasive Urology

• Robotic urologic surgery — full spectrum (prostate, bladder, kidney, adrenal, upper tract)
• Retroperitoneal laparoscopic surgery
• Flexible ureteroscopy with holmium laser lithotripsy for urinary stones
• Percutaneous nephrolithotomy (PCNL) for large kidney stones
• Laparoscopic pyeloplasty for UPJ obstruction
• Robotic pyeloplasty

Benign Prostatic Hyperplasia (BPH)

• Holmium laser enucleation of the prostate (HoLEP)
• Thulium laser enucleation of the prostate (ThuLEP)
• Transurethral resection of the prostate (TURP)
• Photoselective vaporization of the prostate (PVP)
• Open simple prostatectomy for very large prostates

Multidisciplinary Oncology

• Neoadjuvant and adjuvant chemotherapy coordination for bladder cancer
• Hormone therapy and novel androgen receptor pathway inhibitors for prostate cancer
• Targeted therapy (sunitinib, pazopanib, cabozantinib) and immunotherapy (nivolumab, pembrolizumab) coordination for kidney cancer
• PSMA PET-CT guided staging and treatment planning for prostate cancer
• Multidisciplinary tumor board case management

Clinical Excellence & Innovation

Dr. Xu has performed thousands of urologic procedures throughout his distinguished career at Ruijin Hospital, one of Shanghai's most prestigious academic medical centers. His department manages the full spectrum of urologic diseases with a particular strength in urologic oncology and minimally invasive surgery.

Dr. Xu has contributed to several important advances in urologic surgery at Ruijin Hospital:

• Robotic Urology Program: Established and leads a comprehensive robotic urology program at Ruijin Hospital, with extensive experience in robotic radical prostatectomy, radical cystectomy, partial nephrectomy, and adrenalectomy — one of Shanghai's most active robotic urology centers
• Retroperitoneal Laparoscopic Expertise: Developed particular expertise in retroperitoneal laparoscopic approaches for kidney, adrenal, and upper tract surgery, offering patients a less invasive alternative with faster recovery
• Nerve-Sparing Prostatectomy: Refined nerve-sparing techniques for robotic radical prostatectomy to maximize preservation of urinary continence and erectile function after surgery
• Complex Urinary Diversion: Extensive experience in orthotopic neobladder reconstruction after radical cystectomy, offering patients the most natural form of urinary diversion
• Vena Cava Thrombectomy: Experienced in open and minimally invasive surgery for renal cell carcinoma with inferior vena cava tumor thrombus, including level III and IV thrombi
• ERAS for Urology: Implemented enhanced recovery after surgery protocols for major urologic procedures, reducing hospital stay and improving patient outcomes

Research & Academic Contributions

Dr. Xu is an active researcher with numerous peer-reviewed publications in leading Chinese and international urology and oncology journals. His research focuses on:

• Outcomes of robotic and laparoscopic urologic oncology surgery
• Nerve-sparing techniques and functional outcomes after radical prostatectomy
• Urinary diversion and quality of life after radical cystectomy
• Nephron-sparing surgery for renal tumors
• Adrenal tumor surgery outcomes
• Perioperative management and ERAS in urologic surgery
• Novel systemic therapies for urologic cancers

He participates in national and international clinical trials in urologic oncology and regularly presents his work at major conferences including the European Association of Urology (EAU) Annual Congress, the American Urological Association (AUA) Annual Meeting, and the Chinese Urological Association Annual Meeting.

Training & Education

As a professor at Shanghai Jiao Tong University School of Medicine, Dr. Xu is committed to training the next generation of urologists. He supervises graduate students and residents, and Ruijin Hospital's Department of Urology serves as a national training base for minimally invasive and robotic urologic surgery.

His trainees receive comprehensive exposure to the full spectrum of urologic surgery in a high-volume academic environment, with particular emphasis on robotic and laparoscopic techniques, urologic oncology, and multidisciplinary cancer management.

Hospital Affiliation

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
197 Ruijin Er Road, Huangpu District, Shanghai 200025

Ruijin Hospital is one of Shanghai's most prestigious and historic academic medical centers, consistently ranked among China's top hospitals. The Department of Urology features:

• State-of-the-art robotic surgery systems (da Vinci Xi) dedicated to urologic procedures
• Advanced laparoscopic urologic surgery suites (transperitoneal and retroperitoneal)
• Specialized urology ICU and ward
• Comprehensive urodynamics laboratory
• Advanced imaging (MRI with prostate protocol, CT, ultrasound, PSMA PET-CT)
• Multidisciplinary urologic oncology tumor board with weekly case conferences
• Dedicated prostate cancer, bladder cancer, kidney cancer, and adrenal tumor clinics
• Urinary stone center with flexible ureteroscopy and PCNL capabilities
• Functional urology and continence clinic
• International patient services with English-speaking coordinators

Patient Care Philosophy

• Patient-Centered Care: Every treatment plan is individualized based on cancer characteristics, patient anatomy, functional goals, and personal circumstances
• Minimally Invasive First: Robotic and laparoscopic approaches prioritized to minimize surgical trauma, reduce recovery time, and preserve function
• Function Preservation: Nerve-sparing techniques for prostate cancer, nephron-sparing for kidney cancer, and continence-optimizing approaches throughout
• Oncologic Precision: Committed to achieving optimal cancer control while minimizing morbidity and preserving quality of life
• Multidisciplinary Collaboration: Complex oncology cases reviewed by a dedicated tumor board integrating urology, medical oncology, radiation oncology, and radiology
• Evidence-Based Practice: Treatment decisions guided by the latest EAU and AUA guidelines and ongoing research
• Transparent Communication: Clear, honest communication about diagnosis, treatment options, risks, and expected outcomes
• Quality of Life Focus: Emphasizes optimal urinary function, continence, and sexual function after treatment

Why Choose Dr. Xu Danfeng?

• Robotic Urology Leader: One of Shanghai's most experienced robotic urologic surgeons, covering the full spectrum of urologic oncology procedures
• Comprehensive Urologic Oncology: Expert in prostate, bladder, kidney, adrenal, and upper tract cancer surgery
• Retroperitoneal Laparoscopic Expertise: Specialized skill in retroperitoneal approaches for kidney and adrenal surgery, minimizing recovery time
• Nerve-Sparing Excellence: Refined techniques to maximize continence and potency preservation after radical prostatectomy
• Complex Reconstruction: Extensive experience in orthotopic neobladder and continent urinary diversion after cystectomy
• Prestigious Academic Center: Ruijin Hospital is one of China's top-ranked hospitals with full multidisciplinary resources
• Cost-Effective Excellence: Urologic surgery costs in Shanghai are typically 60-75% lower than in the US or Europe
• International Patient Experience: Experienced in coordinating care for patients from overseas

Conditions Treated

Urologic Cancers

• Prostate cancer — localized, locally advanced, and high-risk
• Bladder cancer — non-muscle-invasive and muscle-invasive
• Renal cell carcinoma (kidney cancer) — all stages including with vena cava thrombus
• Upper tract urothelial carcinoma (renal pelvis and ureter)
• Adrenal tumors — adenoma, pheochromocytoma, adrenocortical carcinoma
• Testicular cancer (surgical management)
• Penile cancer (surgical management)

Benign Urologic Conditions

• Benign prostatic hyperplasia (BPH) — all sizes
• Lower urinary tract symptoms (LUTS)
• Urinary stone disease (kidney, ureter, bladder)
• Ureteropelvic junction (UPJ) obstruction
• Urethral stricture
• Urinary incontinence (stress and urge)
• Neurogenic bladder
• Adrenal incidentaloma
• Renal cysts (complex)

International Patient Services

China Medical Concierge - Shanghai (CMCS) provides comprehensive support for international patients seeking urologic care with Dr. Xu Danfeng at Ruijin Hospital.

Pre-Treatment Support

• Medical Record Review: Our team works with Ruijin Hospital to review your PSA results, biopsy pathology, imaging, and urodynamic studies to assess diagnosis and treatment options
• Virtual Consultation: Arrange a video consultation with Dr. Xu's team to discuss your case and treatment plan
• Pre-operative Staging Workup: Coordination of comprehensive imaging including MRI prostate protocol, CT, PSMA PET-CT, and urodynamic studies
• Tumor Board Presentation: Your oncology case can be presented at the multidisciplinary urologic oncology tumor board
• Second Opinion: Expert second opinion on diagnosis, staging, and optimal treatment strategy
• Cost Transparency: Detailed cost estimate including evaluation, surgery, hospitalization, and follow-up
• Visa Assistance: Guidance on obtaining medical visa and invitation letters
• Accommodation: Help finding suitable housing near Ruijin Hospital for patient and family

During Treatment

• Professional Medical Interpretation: Experienced interpreters for all medical interactions
• Hospital Admission Support: Assistance with registration, payment, and navigation
• Family Support: Accommodation and support for accompanying family members
• Surgical Coordination: Communication with family during surgery
• ICU & Ward Support: Daily updates and interpretation during hospital stay
• Post-operative Care: Comprehensive support during recovery including catheter management and wound care
• Medication Management: Assistance with post-operative medications and pain management
• 24/7 Emergency Support: Round-the-clock assistance throughout your stay

Post-Treatment Care

• Discharge Planning: Coordination of post-discharge care and monitoring
• Medical Report Translation: Complete translation of surgical reports, pathology, and discharge summaries
• Adjuvant Therapy Coordination: Assistance with arranging hormone therapy, targeted therapy, immunotherapy, or radiation if recommended
• Follow-up Coordination: Arrange post-operative clinic visits and PSA/imaging surveillance
• Long-term Monitoring Plan: Clear guidance on ongoing surveillance schedule
• Complication Management: Support for any post-operative complications including continence and erectile function rehabilitation
• Telemedicine Follow-up: Virtual consultations for ongoing care after returning home
• Coordination with Home Physicians: Communication with your local urologist or oncologist
• Lifelong Support: Ongoing assistance throughout your urologic care journey

Schedule Your Consultation

If you or a loved one has been diagnosed with prostate cancer, bladder cancer, kidney cancer, an adrenal tumor, or another urologic condition, Dr. Xu Danfeng at Ruijin Hospital offers world-class robotic and minimally invasive urologic surgical expertise with outcomes that rival the best centers globally, at a fraction of Western costs.

Contact China Medical Concierge - Shanghai today to:

• Request a medical record review to assess diagnosis and treatment options
• Schedule a virtual consultation with Dr. Xu's urology team
• Have your oncology case presented at the multidisciplinary urologic tumor board
• Receive a detailed treatment plan and cost estimate
• Start your journey toward expert robotic urologic care in Shanghai

Bridging international patients with Shanghai's finest urologists — because robotic precision and minimally invasive expertise deliver the best outcomes with the fastest recovery.